Nadroparine Calcium Aspen

Active Ingredient:: Nadroparin Calcium
Origin:: EU

Nadroparine Calcium Aspen (Nadroparin Calcium)

Q: What is Nadroparine Calcium Aspen used for?

Nadroparine Calcium Aspen contains nadroparin calcium, a low molecular weight heparin used to prevent and treat venous thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and to provide anticoagulation during hemodialysis or after major surgery.

Q: How does nadroparin calcium work?

Nadroparin calcium binds to antithrombin III, greatly enhancing its ability to inhibit factor Xa and, to a lesser extent, thrombin (factor IIa). This blocks the conversion of prothrombin to thrombin and the formation of fibrin, thereby reducing clot development.

Q: What is the usual dose of Nadroparine Calcium Aspen?

The prescribed dose of Nadroparine Calcium Aspen is determined by the treating physician based on the specific indication, patient weight, renal function, and clinical situation. Dosing regimens are individualized and should follow the prescriber's instructions.

Q: Is Nadroparine Calcium Aspen safe during pregnancy or breastfeeding?

Safety data for nadroparin calcium in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

Q: How do I order Nadroparine Calcium Aspen from GNH India?

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Q: How does Nadroparine Calcium Aspen compare with other low molecular weight heparins?

Nadroparin calcium shares the same class mechanism as other LMWHs such as enoxaparin or dalteparin, offering predictable anticoagulation and subcutaneous administration. Differences may include molecular weight, anti‑Xa activity, dosing frequency, and specific regulatory approvals, which clinicians consider when selecting the most appropriate agent.

Q: What are the storage and handling requirements for Nadroparine Calcium Aspen?

The product should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears discolored or contains particles.

Q: How is Nadroparine Calcium Aspen administered?

Nadroparine Calcium Aspen is given by subcutaneous injection, typically into the abdominal wall or thigh. The injection site should be rotated to minimize local irritation, and aseptic technique must be followed to prevent infection.

Q: What are the most serious risks associated with Nadroparine Calcium Aspen?

The most serious risks include major bleeding events such as intracranial or gastrointestinal hemorrhage, and heparin‑induced thrombocytopenia (HIT), an immune‑mediated reaction that can paradoxically increase clot formation. Immediate medical attention is required if these occur.

Q: Who should not use Nadroparine Calcium Aspen?

Patients with active major bleeding, a known hypersensitivity to nadroparin or other heparins, a history of heparin‑induced thrombocytopenia, or uncontrolled severe hypertension should avoid using this medication. Contraindications must be confirmed by the prescribing clinician.

Nadroparin calcium, the active ingredient in Nadroparine Calcium Aspen, is a low molecular weight heparin presented as a sterile solution for subcutaneous use. It is employed to prevent and treat venous thromboembolic events in adult patients undergoing surgery, dialysis, or at risk of clot formation.
GNH India supplies Nadroparine Calcium Aspen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aspen Pharma Trading Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nadroparin calcium is a low molecular weight heparin used in the management of venous thromboembolism and related conditions.

Prevention of deep vein thrombosis (DVT): reduces postoperative clot risk in surgical patients.
Treatment of acute pulmonary embolism (PE): facilitates resolution of existing emboli.
Anticoagulation during hemodialysis: maintains circuit patency and prevents clotting.
Prophylaxis of venous thromboembolism in orthopedic surgery: lowers incidence of postoperative thrombosis.

How It Works

Nadroparin calcium binds to antithrombin III, markedly enhancing its inhibition of factor Xa and, to a lesser extent, thrombin (factor IIa). This accelerated inhibition disrupts the conversion of prothrombin to thrombin and the generation of fibrin, thereby impeding clot formation while preserving a predictable anticoagulant profile.

Side Effects

Common Side Effects

Injection site pain: mild discomfort at the injection site.
Bruising at injection site: small hematoma formation.
Erythema: localized redness.
Minor bleeding: gum, nose or easy bruising.
Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects

Heparin‑induced thrombocytopenia (HIT): immune‑mediated platelet drop.
Major bleeding: intracranial or gastrointestinal hemorrhage.
Allergic anaphylaxis: severe hypersensitivity reaction.
Spinal or epidural hematoma: bleeding in neuraxial spaces.
Severe thrombocytopenia: platelet count <20,000/µL.

Precautions & Warnings

Nadroparine Calcium Aspen requires careful clinical assessment before use.

Renal impairment: adjust dose and monitor anti‑Xa levels.
History of HIT: avoid use due to risk of recurrence.
Active bleeding: contraindicated until bleeding is controlled.
Upcoming surgery: discontinue according to procedural guidelines.
Pregnancy: use only if potential benefit justifies risk.
Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Nadroparine Calcium Aspen may interact with several drug classes, altering bleeding risk.

Major Interactions (Avoid)

Concurrent anticoagulants (warfarin, DOACs): additive anticoagulation.
Antiplatelet agents (aspirin, clopidogrel): heightened bleeding.
Thrombolytic therapy (alteplase): synergistic hemorrhagic risk.

Moderate Interactions (Monitor Closely)

NSAIDs (ibuprofen, naproxen): increased mucosal bleeding.
SSRIs/SNRIs (fluoxetine, venlafaxine): potential for mucosal bleeding.
Corticosteroids (prednisone): may exacerbate gastrointestinal bleeding.
ACE inhibitors (lisinopril): rare reports of enhanced anticoagulant effect.
Vitamin K antagonists (acenocoumarol): requires INR monitoring.

Frequently Asked Questions

Nadroparine Calcium Aspen contains nadroparin calcium, a low molecular weight heparin used to prevent and treat venous thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and to provide anticoagulation during hemodialysis or after major surgery.

Nadroparin calcium binds to antithrombin III, greatly enhancing its ability to inhibit factor Xa and, to a lesser extent, thrombin (factor IIa). This blocks the conversion of prothrombin to thrombin and the formation of fibrin, thereby reducing clot development.

The prescribed dose of Nadroparine Calcium Aspen is determined by the treating physician based on the specific indication, patient weight, renal function, and clinical situation. Dosing regimens are individualized and should follow the prescriber's instructions.

Safety data for nadroparin calcium in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Nadroparin calcium shares the same class mechanism as other LMWHs such as enoxaparin or dalteparin, offering predictable anticoagulation and subcutaneous administration. Differences may include molecular weight, anti‑Xa activity, dosing frequency, and specific regulatory approvals, which clinicians consider when selecting the most appropriate agent.

The product should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears discolored or contains particles.

Nadroparine Calcium Aspen is given by subcutaneous injection, typically into the abdominal wall or thigh. The injection site should be rotated to minimize local irritation, and aseptic technique must be followed to prevent infection.

The most serious risks include major bleeding events such as intracranial or gastrointestinal hemorrhage, and heparin‑induced thrombocytopenia (HIT), an immune‑mediated reaction that can paradoxically increase clot formation. Immediate medical attention is required if these occur.

Patients with active major bleeding, a known hypersensitivity to nadroparin or other heparins, a history of heparin‑induced thrombocytopenia, or uncontrolled severe hypertension should avoid using this medication. Contraindications must be confirmed by the prescribing clinician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 18 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.